Work

Current perspectives between metabolic syndrome and cancer

Year: 2016
Type: review
Abstract: // Carla Micucci 1 , Debora Valli 1 , Giulia Matacchione 1 and Alfonso Catalano 1 1 Department of Clinical and Molecular Sciences, Polytechnic University of Marche, School of Medicine, Ancona, Italy Correspondence to: Alfonso Catalano, email: // Keywords : metabolic syndrome, cancer risk, visceral adiposity, hyperglycemia, inflammation Received : September 30, 2015 Accepted : February 20, 2016 Published : March 24, 2016 Abstract Metabolic syndrome is a cluster of risk factors that lead to cardiovascular morbidity and mortality. Recent studies linked metabolic syndrome and several types of cancer. Although metabolic syndrome may not necessarily cause cancer, it is linked to poorer cancer outcomes including increased risk of recurrence and overall mortality. This review tends to discuss the major biological and physiological alterations involved in the increase of incidence and mortality of cancer patients affected by metabolic syndrome. We focus on metabolic syndrome-associated visceral adiposity, hyperinsulinemia, hyperglycemia, insulin-like growth factor (IGF-I) pathway as well as estrogen signaling and inflammation. Several of these factors are also involved in carcinogenesis and cancer progression. A better understanding of the link between metabolic syndrome and cancer may provide new insight about oncogenesis. Moreover, prevention of metabolic syndrome – related alterations may be an important aspect in the management of cancer patients during simultaneous palliative care.
Source: Oncotarget
Language: English
Open Access status: diamond
OpenAlex ID: W2325075659
FWCI: 1.43
Cites: 119
Cited by: 123
Related to: 10